You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

signaling pathway

Showing 26 - 50 of 4,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg)

Not yet recruiting
  • Rheumatoid Arthritis
  • Placebo
  • +2 more
  • (no location specified)
Jul 27, 2022

Parkinson Disease, Gait Analysis, Therapy, Directly Observed Trial (Terazosin)

Not yet recruiting
  • Parkinson Disease
  • +3 more
  • (no location specified)
May 3, 2023

Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

Recruiting
  • Myocardial Infarction
  • +2 more
  • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
  • Clopidogrel + Aspirin for CCS patients
  • Messina, Italy
    AOU Policlinico G. Martino
Jan 21, 2023

Sarcopenia Trial in Aarhus (insect, pea or whey protein)

Active, not recruiting
  • Sarcopenia
  • insect, pea or whey protein
  • Aarhus, Denmark
    Department of Public Health,
May 17, 2022

The Kallikrein-Kinin System in Cardiac Surgery

Recruiting
  • Cardiosurgery
    • Wuhan, Hubei, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 6, 2023

    LKDS and PBSS of KOA Based on Enhancement of Inflammatory

    Recruiting
    • Knee Osteoarthritis
    • +2 more
    • cross-sectional study without intervention
    • Beijing, Beijing, China
      Dongzhimen Hospital
    Jan 28, 2022

    Rheumatoid Arthritis Patients Treated With JAK-inhibitor

    Recruiting
    • Rheumatoid Arthritis
    • Upadacitinib <15 MG [Rinvoq]
    • Montpellier, France
      CHU de Montpellier
    Jan 12, 2022

    Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)

    Recruiting
    • Down Syndrome
    • +5 more
    • Aurora, Colorado
      Linda Crnic Institute for Down Syndrome
    Jan 17, 2023

    Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

    Not yet recruiting
    • Rheumatoid Arthritis
    • "apigenin" and "glycyrrhizin"
    • +2 more
    • (no location specified)
    Mar 27, 2023

    Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

    Not yet recruiting
    • Optic Pathway Glioma
    • Rome, Italy
      Catholic University, Policlinico A. Gemelli (Hospital)
    Feb 17, 2023

    Advanced Breast Cancer Trial in Spain (CB-103)

    Active, not recruiting
    • Advanced Breast Cancer
    • Alzira, Spain
    • +14 more
    Jun 7, 2022

    Klotho _ LRP-6 _ Gastric Adenocarcinoma

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Prognostic study
    • (no location specified)
    Jan 29, 2023

    Branch Retinal Vein Occlusion Trial in Damietta (aflibercept (2mg/0.05ml))

    Completed
    • Branch Retinal Vein Occlusion
    • aflibercept (2mg/0.05ml)
    • Damietta, Egypt
      Akram Fekry Elgazzar
    Nov 22, 2023

    Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Tadalafil 20Mg Oral Tablet
    • Pentoxifylline 400 MG Oral Tablet
    • (no location specified)
    Aug 2, 2022

    Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

    Active, not recruiting
    • Low-Grade Gliomas
    • +2 more
    • Birmingham, Alabama
    • +14 more
    Jan 25, 2023

    Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)

    Recruiting
    • Axial Spondyloarthritis
    • Psoriatic Arthritis
    • serum raftlin-1 protein levels
    • Istanbul, Turkey
      Bezmialem University
    Mar 22, 2023

    IBD, Crohn Disease, Ulcerative Colitis Trial in Orléans (Blood and fecal samples, Coolonic biopsies)

    Recruiting
    • Inflammatory Bowel Diseases
    • +2 more
    • Blood and fecal samples
    • Coolonic biopsies
    • Orléans, France
      CHR Orléans
    Jun 14, 2023

    Parkinson Disease Trial in Mansoura (carbidopa-levodopa, Pentoxifylline 400 MG)

    Not yet recruiting
    • Parkinson Disease
    • Mansoura, Egypt
      Faculty of Medicine, Mansoura University
    Jul 25, 2023

    Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Diabete Type 2
    • Cairo, Egypt
      clinical research uint- El-sheikh zayed specialized hospital SMC
    Oct 8, 2023

    Atrophy, Disuse, Atrophy, Muscular Trial (Resistance Training Preconditioning, Control)

    Not yet recruiting
    • Atrophy, Disuse
    • Atrophy, Muscular
    • Resistance Training Preconditioning
    • Control
    • (no location specified)
    Feb 26, 2023

    Huntington Disease Trial in Montpellier (procedure, genetic, other)

    Recruiting
    • Huntington Disease
    • Brain MRI
    • +3 more
    • Montpellier, France
      University Hospital of Montpellier
    Dec 23, 2021

    Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia in Remission
    • Recurrent Adult Acute Myeloid Leukemia
    • Aurora, Colorado
    • +1 more
    Dec 30, 2021

    Healthy Participants Trial (Acute Maastricht Stress Test (MAST), active condition., Acute Maastricht Stress Test (MAST),

    Not yet recruiting
    • Healthy Participants
    • Acute Maastricht Stress Test (MAST), active condition.
    • Acute Maastricht Stress Test (MAST), placebo condition
    • (no location specified)
    Dec 21, 2022

    Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas

    Recruiting
    • Esophagus Adenocarcinoma
    • +2 more
    • Dallas, Texas
      Dallas VA Medical Center
    Nov 2, 2021

    Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)

    Recruiting
    • Estrogen Receptor-positive Breast Cancer
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Sep 20, 2022